Literature DB >> 2822074

The reactivity of alpha-1-antitrypsin with Lens culinaris agglutinin and its usefulness in the diagnosis of neoplastic diseases of the liver.

C Sekine1, Y Aoyagi, Y Suzuki, F Ichida.   

Abstract

The reactivity of alpha-1-antitrypsin (AAT) with Lens culinaris agglutinin (LCA) was studied by crossed immuno-affinity electrophoresis of the sera of 246 subjects from 6 groups (acute virus hepatitis, chronic hepatitis, liver cirrhosis, hepatocellular carcinoma (HCC), carcinoma metastatic to the liver and normal controls). Two species of AAT (LCA-reactive and -nonreactive species) were detected on crossed immuno-affinity electrophoresis in a gel containing LCA. The percentages of LCA-reactive species of AAT in neoplastic diseases of the liver were significantly higher than those in benign liver diseases and normal controls. There was no correlation between the percentage of LCA-reactive species of AAT and serum AAT concentration in any group. Furthermore, in studying 15 pairs of serum samples before and after the subsequent development of HCC, the percentage of LCA-reactive species of AAT after HCC occurrence was significantly higher than that before, although there was no statistically significant difference between the serum AAT concentration before and after development of the disease. The latter 15 patients were all of the normal protease inhibitor phenotype (PiMM) and no change in phenotype was observed before and after the development of HCC. The results indicate that measurement of the reactivity of AAT with LCA can be a useful marker for the diagnosis of HCC and carcinoma metastatic to the liver, especially when serum concentrations of alpha-foetoprotein or other tumour markers are within the normal ranges.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822074      PMCID: PMC2002189          DOI: 10.1038/bjc.1987.205

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  Immunofixation after electrofocusing: improved method for specific detection of serum proteins with determination of isoelectric points. I. Immunofixation print technique for detection of alpha-1-protease inhibitor.

Authors:  P Arnaud; G B Wilson; J Koistinen; H H Fudenberg
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

2.  Change in fucosylation of alpha-fetoprotein on malignant transformation of liver cells.

Authors:  Y Aoyagi; M Isemura; Y Suzuki; C Sekine; K Soga; T Ozaki; F Ichida
Journal:  Lancet       Date:  1986-01-25       Impact factor: 79.321

3.  Cirrhosis and malignant hepatoma in alpha 1-antitrypsin deficiency.

Authors:  S Eriksson; I Hägerstrand
Journal:  Acta Med Scand       Date:  1974-06

4.  Liver disease in adults with alpha-1 -antitrypsin deficiency.

Authors:  N O Berg; S Eriksson
Journal:  N Engl J Med       Date:  1972-12-21       Impact factor: 91.245

5.  Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder.

Authors:  H L Sharp; R A Bridges; W Krivit; E F Freier
Journal:  J Lab Clin Med       Date:  1969-06

6.  Crossed immuno-affinoelectrophoresis. An analytical method to predict the result of affinity chromatography.

Authors:  T C Bog-Hansen
Journal:  Anal Biochem       Date:  1973-12       Impact factor: 3.365

Review 7.  Structure and variation of human alpha 1-antitrypsin.

Authors:  R W Carrell; J O Jeppsson; C B Laurell; S O Brennan; M C Owen; L Vaughan; D R Boswell
Journal:  Nature       Date:  1982-07-22       Impact factor: 49.962

8.  Alpha-antitrypsin deposition in primary hepatic carcinomas.

Authors:  P E Palmer; H J Wolfe
Journal:  Arch Pathol Lab Med       Date:  1976-05       Impact factor: 5.534

9.  Studies on the oligosaccharide chains of human alpha 1-protease inhibitor. II. Structure of oligosaccharides.

Authors:  T Mega; E Lujan; A Yoshida
Journal:  J Biol Chem       Date:  1980-05-10       Impact factor: 5.157

10.  Differential reactivity of alpha-fetoprotein with lectins and evaluation of its usefulness in the diagnosis of hepatocellular carcinoma.

Authors:  Y Aoyagi; Y Suzuki; M Isemura; K Soga; T Ozaki; T Ichida; K Inoue; H Sasaki; F Ichida
Journal:  Gan       Date:  1984-09
View more
  4 in total

1.  N-linked glycosylation of the liver cancer biomarker GP73.

Authors:  Pamela A Norton; Mary Ann Comunale; Jonathan Krakover; Lucy Rodemich; Natalie Pirog; Anthony D'Amelio; Ramila Philip; Anand S Mehta; Timothy M Block
Journal:  J Cell Biochem       Date:  2008-05-01       Impact factor: 4.429

Review 2.  Carbohydrate-based measurements on alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.

Authors:  Y Aoyagi
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

3.  Alpha-1-antitrypsin in pathogenesis of hepatocellular carcinoma.

Authors:  Aleksandra Topic; Mila Ljujic; Dragica Radojkovic
Journal:  Hepat Mon       Date:  2012-10-30       Impact factor: 0.660

4.  Serum concentration of alpha-1 antitrypsin is significantly higher in colorectal cancer patients than in healthy controls.

Authors:  Sergio Pérez-Holanda; Ignacio Blanco; Manuel Menéndez; Luis Rodrigo
Journal:  BMC Cancer       Date:  2014-05-21       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.